RxDoctor Payments Data

Eric Traviss

Nurse Practitioner · Sioux Falls, SDNPI 1568875102

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 67.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $2,229 and has fallen 86.7% since, to $298 in 2025. Among nurse practitioner clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,177in general payments, 2019–2025

Across 44 payments — averaging $72.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Teleflex LLC$373
  • Johnson & Johnson$187
  • Sumitomo Pharma America, Inc.$93
  • Immunitybio, Inc.$75
  • Antares Pharma, Inc.$62
  • plus $259 from 12 others

What the payments were for

  • Travel & lodging$1,75155%
  • Food & beverage$1,42745%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,177 in reported general payments places this provider in the 90th percentile of 504 nurse practitioner providers in South Dakota.

See all nurse practitioner providers in South Dakota

Medicare billing

Part B allowed, 2024
$63,508
Medicare patients
429
Services billed
3,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron41$28,409
Tamsulosin Hcl191$3,033
Methenamine Hippurate28$1,487
Testosterone Cypionate28$1,010
Silodosin19$859
Finasteride73$754
Cephalexin76$325
Oxybutynin Chloride11$202
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim33$111
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$83
Tramadol Hcl44$46

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →